MyHealth@Eu Patient Summary
1.0.0-ci-build - ci-build
150
MyHealth@Eu Patient Summary
1.0.0-ci-build - ci-build
150
MyHealth@Eu Patient Summary - Local Development build (v1.0.0-ci-build) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://terminology.ehdsi.eu/ValueSet/eHDSIOncologyDisease | Version: 1.0.0-ci-build | |||
| Standards status: Draft | Maturity Level: 1 | Computable Name: EHDSIOncologyDisease | ||
| Other Identifiers: OID:1.3.6.1.4.1.12559.11.10.1.3.1.42.93 | ||||
The Value Set is used for coding the site (topography) and the histology (morphology) of neoplasms
References
http://terminology.hl7.org/CodeSystem/icd-o-3 version Not Stated (use latest from terminology server)| Code | Display |
| 8000/0 | Neoplasm, benign |
| 8000/1 | Neoplasm, uncertain whether benign or malignant |
| 8000/3 | Neoplasm, malignant |
| 8000/6 | Neoplasm, metastatic |
| 8000/9 | Neoplasm, malignant, uncertain whether primary or metastatic |
| 8001/0 | Tumour cells, benign |
| 8001/1 | Tumour cells, uncertain whether benign or malignant |
| 8001/3 | Tumour cells, malignant |
| 8002/3 | Malignant tumour, small cell type |
| 8003/3 | Malignant tumour, giant cell type |
| 8004/3 | Malignant tumour, spindle cell type |
| 8005/0 | Clear cell tumour, NOS |
| 8005/3 | Malignant tumour, clear cell type |
| 8010/0 | Epithelial tumour, benign |
| 8010/2 | Carcinoma in situ, NOS |
| 8010/3 | Carcinoma, NOS |
| 8010/6 | Carcinoma, metastatic, NOS |
| 8010/9 | Carcinomatosis |
| 8011/0 | Epithelioma, benign |
| 8011/3 | Epithelioma, malignant |
| 8012/3 | Large cell carcinoma, NOS |
| 8013/3 | Large cell neuroendocrine carcinoma |
| 8014/3 | Large cell carcinoma with rhabdoid phenotype |
| 8015/3 | Glassy cell carcinoma |
| 8020/3 | Carcinoma, undifferentiated, NOS |
| 8021/3 | Carcinoma, anaplastic, NOS |
| 8022/3 | Pleomorphic carcinoma |
| 8023/3 | Nuclear protein in testis (NUT) associated carcinoma |
| 8030/3 | Giant cell and spindle cell carcinoma |
| 8031/3 | Giant cell carcinoma |
| 8032/3 | Spindle cell carcinoma, NOS |
| 8033/3 | Pseudosarcomatous carcinoma |
| 8034/3 | Polygonal cell carcinoma |
| 8035/3 | Carcinoma with osteoclast-like giant cells |
| 8040/0 | Tumourlet, benign |
| 8040/1 | Tumourlet, NOS |
| 8041/3 | Small cell carcinoma, NOS |
| 8042/3 | Oat cell carcinoma |
| 8043/3 | Small cell carcinoma, fusiform cell |
| 8044/3 | Small cell carcinoma, intermediate cell |
| 8045/3 | Combined small cell carcinoma |
| 8046/3 | Non-small cell carcinoma |
| 8050/0 | Papilloma, NOS |
| 8050/2 | Papillary carcinoma in situ |
| 8050/3 | Papillary carcinoma, NOS |
| 8051/0 | Verrucous papilloma |
| 8051/3 | Verrucous carcinoma, NOS |
| 8052/0 | Squamous cell papilloma, NOS |
| 8052/2 | Papillary squamous cell carcinoma, non-invasive |
| 8052/3 | Papillary squamous cell carcinoma |
| 8053/0 | Squamous cell papilloma, inverted |
| 8054/0 | Warty dyskeratoma |
| 8054/3 | Warty carcinoma |
| 8060/0 | Squamous papillomatosis |
| 8070/0 | Actinic keratosis |
| 8070/2 | Squamous cell carcinoma in situ, NOS |
| 8070/3 | Squamous cell carcinoma, NOS |
| 8070/6 | Squamous cell carcinoma, metastatic, NOS |
| 8071/2 | Differentiated intraepithelial neoplasia |
| 8071/3 | Squamous cell carcinoma, keratinizing, NOS |
| 8072/0 | Large cell acanthoma |
| 8072/3 | Squamous cell carcinoma, large cell, nonkeratinizing, NOS |
| 8073/3 | Squamous cell carcinoma, small cell, nonkeratinizing |
| 8074/3 | Squamous cell carcinoma, spindle cell |
| 8075/3 | Squamous cell carcinoma, adenoid |
| 8076/2 | Squamous cell carcinoma in situ with questionable stromal invasion |
| 8076/3 | Squamous cell carcinoma, microinvasive |
| 8077/0 | Squamous intraepithelial neoplasia, low grade |
| 8077/2 | Squamous intraepithelial neoplasia, high grade |
| 8078/3 | Squamous cell carcinoma with horn formation |
| 8080/2 | Queyrat erythroplasia |
| 8081/2 | Bowen disease |
| 8082/3 | Lymphoepithelial carcinoma |
| 8083/3 | Basaloid squamous cell carcinoma |
| 8084/0 | Clear cell acanthoma |
| 8084/3 | Squamous cell carcinoma, clear cell type |
| 8085/3 | Squamous cell carcinoma, HPV-positive |
| 8086/3 | Squamous cell carcinoma, HPV-negative |
| 8090/1 | Basal cell tumour |
| 8090/3 | Basal cell carcinoma, NOS |
| 8091/3 | Superficial basal cell carcinoma |
| 8092/3 | Infiltrating basal cell carcinoma, NOS |
| 8093/3 | Basal cell carcinoma, fibroepithelial |
| 8094/3 | Basosquamous carcinoma |
| 8095/3 | Metatypical carcinoma |
| 8096/0 | Intraepidermal epithelioma of Jadassohn |
| 8097/3 | Basal cell carcinoma, nodular |
| 8098/3 | Adenoid basal carcinoma |
| 8100/0 | Trichoepithelioma |
| 8100/3 | Trichoblastic carcinoma |
| 8101/0 | Trichofolliculoma |
| 8102/0 | Trichilemmoma |
| 8102/3 | Trichilemmocarcinoma |
| 8103/0 | Pilar tumour |
| 8103/1 | Proliferating trichilemmal cyst |
| 8104/0 | Pilar sheath acanthoma |
| 8110/0 | Pilomatricoma, NOS |
| 8110/3 | Pilomatrical carcinoma |
| 8120/0 | Urothelial papilloma, NOS |
| 8120/2 | Urothelial carcinoma in situ |
| 8120/3 | Transitional cell carcinoma, NOS |
| 8121/0 | Sinonasal papilloma, exophytic |
| 8121/1 | Sinonasal papilloma, inverted |
| 8121/3 | Schneiderian carcinoma |
| 8122/3 | Urothelial carcinoma, sarcomatoid |
| 8123/3 | Basaloid carcinoma |
| 8124/3 | Cloacogenic carcinoma |
| 8130/1 | Papillary urothelial neoplasm of low malignant potential |
| 8130/2 | Papillary urothelial carcinoma, non-invasive |
| 8130/3 | Papillary urothelial carcinoma |
| 8131/3 | Urothelial carcinoma, micropapillary |
| 8140/0 | Adenoma, NOS |
| 8140/1 | Atypical adenoma |
| 8140/2 | Adenocarcinoma in situ, NOS |
| 8140/3 | Adenocarcinoma, NOS |
| 8140/6 | Adenocarcinoma, metastatic, NOS |
| 8141/3 | Scirrhous adenocarcinoma |
| 8142/3 | Linitis plastica |
| 8143/3 | Superficial spreading adenocarcinoma |
| 8144/0 | Adenoma, intestinal type |
| 8144/3 | Adenocarcinoma, intestinal type |
| 8145/3 | Carcinoma, diffuse type |
| 8146/0 | Monomorphic adenoma |
| 8147/0 | Basal cell adenoma |
| 8147/3 | Basal cell adenocarcinoma |
| 8148/0 | Glandular intraepithelial neoplasia, low grade |
| 8148/2 | Glandular intraepithelial neoplasia, high grade |
| 8149/0 | Canalicular adenoma |
| 8150/0 | Pancreatic neuroendocrine microadenoma |
| 8150/3 | Pancreatic neuroendocrine tumour, nonfunctioning |
| 8151/3 | Insulinoma, NOS |
| 8152/3 | Glucagonoma |
| 8153/3 | Gastrinoma |
| 8154/3 | Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) |
| 8155/3 | Vipoma |
| 8156/3 | Somatostatinoma |
| 8158/3 | ACTH-producing tumour |
| 8160/0 | Bile duct adenoma |
| 8160/3 | Cholangiocarcinoma |
| 8161/0 | Bile duct cystadenoma |
| 8161/3 | Bile duct cystadenocarcinoma |
| 8162/3 | Perihilar cholangiocarcinoma |
| 8163/0 | Pancreatobiliary neoplasm, non-invasive |
| 8163/2 | Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia |
| 8163/3 | Pancreatobiliary-type carcinoma |
| 8170/0 | Liver cell adenoma |
| 8170/3 | Hepatocellular carcinoma, NOS |
| 8171/3 | Hepatocellular carcinoma, fibrolamellar |
| 8172/3 | Hepatocellular carcinoma, scirrhous |
| 8173/3 | Hepatocellular carcinoma, spindle cell variant |
| 8174/3 | Hepatocellular carcinoma, clear cell type |
| 8175/3 | Hepatocellular carcinoma, pleomorphic type |
| 8180/3 | Combined hepatocellular carcinoma and cholangiocarcinoma |
| 8190/0 | Trabecular adenoma |
| 8190/3 | Trabecular adenocarcinoma |
| 8191/0 | Embryonal adenoma |
| 8200/0 | Eccrine dermal cylindroma |
| 8200/3 | Adenoid cystic carcinoma |
| 8201/2 | Cribriform carcinoma in situ |
| 8201/3 | Cribriform carcinoma, NOS |
| 8202/0 | Microcystic adenoma |
| 8204/0 | Lactating adenoma |
| 8210/0 | Adenomatous polyp, NOS |
| 8210/2 | Adenocarcinoma in situ in adenomatous polyp |
| 8210/3 | Adenocarcinoma in adenomatous polyp |
| 8211/0 | Tubular adenoma, NOS |
| 8211/3 | Tubular adenocarcinoma |
| 8212/0 | Flat adenoma |
| 8213/0 | Serrated adenoma |
| 8213/3 | Serrated adenocarcinoma |
| 8214/3 | Parietal cell carcinoma |
| 8215/3 | Adenocarcinoma of anal glands |
| 8220/0 | Adenomatous polyposis coli |
| 8220/3 | Adenocarcinoma in adenomatous polyposis coli |
| 8221/0 | Multiple adenomatous polyps |
| 8221/3 | Adenocarcinoma in multiple adenomatous polyps |
| 8230/2 | Ductal carcinoma in situ, solid type |
| 8230/3 | Solid carcinoma, NOS |
| 8231/3 | Carcinoma simplex |
| 8240/3 | Neuroendocrine tumour, NOS |
| 8241/3 | Enterochromaffin cell carcinoid |
| 8242/3 | Enterochromaffin-like cell tumour |
| 8243/3 | Goblet cell carcinoid |
| 8244/3 | Mixed adenoneuroendocrine carcinoma |
| 8245/1 | Tubular carcinoid |
| 8245/3 | Adenocarcinoid tumour |
| 8246/3 | Neuroendocrine carcinoma, NOS |
| 8247/3 | Merkel cell carcinoma |
| 8248/1 | Apudoma |
| 8249/3 | Neuroendocrine tumour, grade 2 |
| 8250/0 | Atypical adenomatous hyperplasia |
| 8250/1 | Pulmonary adenomatosis |
| 8250/2 | Adenocarcinoma in situ of lung, non-mucinous |
| 8250/3 | Lepidic adenocarcinoma |
| 8251/0 | Alveolar adenoma |
| 8251/3 | Alveolar adenocarcinoma |
| 8252/3 | Bronchiolo-alveolar carcinoma, non-mucinous |
| 8253/2 | Adenocarcinoma in situ of lung, mucinous |
| 8253/3 | Adenocarcinoma of lung, mucinous |
| 8254/3 | Adenocarcinoma of lung, mixed mucinous and non-mucinous |
| 8255/3 | Adenocarcinoma with mixed subtypes |
| 8256/3 | Minimally invasive adenocarcinoma, Non-mucinous |
| 8257/3 | Minimally invasive adenocarcinoma, Mucinous |
| 8260/0 | Papillary adenoma, NOS |
| 8260/1 | Aggressive papillary tumour |
| 8260/3 | Papillary adenocarcinoma, NOS |
| 8261/0 | Villous adenoma, NOS |
| 8261/2 | Adenocarcinoma in situ in villous adenoma |
| 8261/3 | Adenocarcinoma in villous adenoma |
| 8262/3 | Villous adenocarcinoma |
| 8263/0 | Tubulovillous adenoma, NOS |
| 8263/2 | Adenocarcinoma in situ in tubulovillous adenoma |
| 8263/3 | Adenocarcinoma in tubulovillous adenoma |
| 8264/0 | Papillomatosis, glandular |
| 8265/3 | Micropapillary carcinoma, NOS |
| 8270/0 | Chromophobe adenoma |
| 8270/3 | Chromophobe carcinoma |
| 8271/0 | Lactotroph adenoma |
| 8272/0 | Pituitary adenoma, NOS |
| 8272/3 | Pituitary carcinoma, NOS |
| 8273/3 | Pituitary blastoma |
| 8280/0 | Acidophil adenoma |
| 8280/3 | Acidophil carcinoma |
| 8281/0 | Mixed acidophil-basophil adenoma |
| 8281/3 | Mixed acidophil-basophil carcinoma |
| 8290/0 | Oxyphilic adenoma |
| 8290/3 | Oxyphilic adenocarcinoma |
| 8300/0 | Basophil adenoma |
| 8300/3 | Basophil carcinoma |
| 8310/0 | Clear cell adenoma |
| 8310/3 | Clear cell adenocarcinoma, NOS |
| 8311/1 | Hypernephroid tumour |
| 8311/3 | Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma |
| 8312/3 | Renal cell carcinoma, NOS |
| 8313/0 | Clear cell adenofibroma |
| 8313/1 | Clear cell borderline tumour |
| 8313/3 | Clear cell adenocarcinofibroma |
| 8314/3 | Lipid-rich carcinoma |
| 8315/3 | Glycogen-rich carcinoma |
| 8316/1 | Multilocular cystic renal neoplasm of low malignant potential |
| 8316/3 | Cyst-associated renal cell carcinoma |
| 8317/3 | Renal cell carcinoma, chromophobe type |
| 8318/3 | Renal cell carcinoma, sarcomatoid |
| 8319/3 | Collecting duct carcinoma |
| 8320/3 | Granular cell carcinoma |
| 8321/0 | Chief cell adenoma |
| 8322/0 | Water-clear cell adenoma |
| 8322/3 | Water-clear cell adenocarcinoma |
| 8323/0 | Mixed cell adenoma |
| 8323/1 | Clear cell papillary renal cell carcinoma |
| 8323/3 | Mixed cell adenocarcinoma |
| 8324/0 | Lipoadenoma |
| 8325/0 | Metanephric adenoma |
| 8330/0 | Follicular adenoma |
| 8330/1 | Atypical follicular adenoma |
| 8330/3 | Follicular carcinoma, NOS |
| 8331/3 | Follicular adenocarcinoma, well differentiated |
| 8332/3 | Follicular adenocarcinoma, trabecular |
| 8333/0 | Microfollicular adenoma, NOS |
| 8333/3 | Fetal adenocarcinoma |
| 8334/0 | Macrofollicular adenoma |
| 8335/1 | Follicular tumour of uncertain malignant potential |
| 8335/3 | Follicular carcinoma, minimally invasive |
| 8336/1 | Hyalinizing trabecular tumour |
| 8337/3 | Poorly differentiated thyroid carcinoma |
| 8339/3 | Follicular carcinoma, encapsulated, angioinvasive |
| 8340/3 | Papillary carcinoma, follicular variant |
| 8341/3 | Papillary microcarcinoma |
| 8342/3 | Papillary carcinoma, oncocytic variant |
| 8343/3 | Papillary carcinoma, encapsulated, of thyroid |
| 8344/3 | Papillary carcinoma, columnar cell |
| 8345/3 | Medullary thyroid carcinoma |
| 8346/3 | Mixed medullary-follicular carcinoma |
| 8347/3 | Mixed medullary-papillary carcinoma |
| 8348/1 | Well differentiated tumour of uncertain malignant potential |
| 8349/1 | Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) |
| 8350/3 | Nonencapsulated sclerosing carcinoma |
| 8360/1 | Multiple endocrine adenomas |
| 8361/0 | Juxtaglomerular tumour |
| 8370/0 | Adrenal cortical adenoma, NOS |
| 8370/3 | Adrenal cortical carcinoma |
| 8371/0 | Adrenal cortical adenoma, compact cell |
| 8372/0 | Adrenal cortical adenoma, pigmented |
| 8373/0 | Adrenal cortical adenoma, clear cell |
| 8374/0 | Adrenal cortical adenoma, glomerulosa cell |
| 8375/0 | Adrenal cortical adenoma, mixed cell |
| 8380/0 | Endometrioid adenoma, NOS |
| 8380/1 | Endometrioid adenoma, borderline malignancy |
| 8380/2 | Endometrioid intraepithelial neoplasia |
| 8380/3 | Endometrioid adenocarcinoma, NOS |
| 8381/0 | Endometrioid adenofibroma, NOS |
| 8381/1 | Endometrioid adenofibroma, borderline malignancy |
| 8381/3 | Endometrioid adenofibroma, malignant |
| 8382/3 | Endometrioid adenocarcinoma, secretory variant |
| 8383/3 | Endometrioid adenocarcinoma, ciliated cell variant |
| 8384/3 | Adenocarcinoma, endocervical type |
| 8390/0 | Skin appendage adenoma |
| 8390/3 | Adnexal adenocarcinoma, NOS |
| 8391/0 | Follicular fibroma |
| 8392/0 | Syringofibroadenoma |
| 8400/0 | Sweat gland adenoma |
| 8400/1 | Sweat gland tumour, NOS |
| 8400/3 | Sweat gland adenocarcinoma |
| 8401/0 | Apocrine adenoma |
| 8401/3 | Apocrine adenocarcinoma |
| 8402/0 | Hidradenoma, NOS |
| 8402/3 | Hidradenocarcinoma |
| 8403/0 | Spiradenoma, NOS |
| 8403/3 | Malignant eccrine spiradenoma |
| 8404/0 | Hidrocystoma |
| 8405/0 | Papillary hidradenoma |
| 8406/0 | Syringocystadenoma papilliferum |
| 8406/3 | Syringocystadenocarcinoma papilliferum |
| 8407/0 | Syringoma, NOS |
| 8407/3 | Microcystic adnexal carcinoma |
| 8408/0 | Eccrine papillary adenoma |
| 8409/0 | Poroma, NOS |
| 8409/2 | Porocarcinoma in situ |
| 8409/3 | Porocarcinoma, NOS |
| 8410/0 | Sebaceoma |
| 8410/3 | Sebaceous carcinoma |
| 8413/3 | Eccrine adenocarcinoma |
| 8420/0 | Ceruminous adenoma |
| 8420/3 | Ceruminous adenocarcinoma |
| 8430/1 | Mucoepidermoid tumour |
| 8430/3 | Mucoepidermoid carcinoma |
| 8440/0 | Cystadenoma, NOS |
| 8440/3 | Cystadenocarcinoma, NOS |
| 8441/0 | Serous cystadenoma, NOS |
| 8441/2 | Serous intraepithelial carcinoma |
| 8441/3 | Serous carcinoma, NOS |
| 8443/0 | Clear cell cystadenoma |
| 8450/0 | Papillary cystadenoma, NOS |
| 8450/3 | Papillary cystadenocarcinoma, NOS |
| 8451/1 | Papillary cystadenoma, borderline malignancy |
| 8452/1 | Solid pseudopapillary tumour of ovary |
| 8452/3 | Solid pseudopapillary neoplasm of pancreas |
| 8453/0 | Intraductal papillary-mucinous adenoma |
| 8453/2 | Intraductal papillary mucinous neoplasm with high grade dysplasia |
| 8453/3 | Intraductal papillary mucinous neoplasm with an associated invasive carcinoma |
| 8454/0 | Cystic tumour of atrio-ventricular node |
| 8460/2 | Serous borderline tumour, micropapillary variant |
| 8460/3 | Low grade serous carcinoma |
| 8461/0 | Serous surface papilloma |
| 8461/3 | High grade serous carcinoma |
| 8470/0 | Mucinous cystadenoma, NOS |
| 8470/2 | Mucinous cystic neoplasm with high-grade dysplasia |
| 8470/3 | Mucinous cystadenocarcinoma, NOS |
| 8472/1 | Mucinous cystic tumour of borderline malignancy |
| 8474/0 | Seromucinous cystadenoma |
| 8474/1 | Seromucinous borderline tumour |
| 8474/3 | Seromucinous carcinoma |
| 8480/0 | Mucinous adenoma |
| 8480/1 | Low grade appendiceal mucinous neoplasm |
| 8480/3 | Mucinous adenocarcinoma |
| 8480/6 | Pseudomyxoma peritonei |
| 8481/3 | Mucin-producing adenocarcinoma |
| 8482/3 | Mucinous carcinoma, gastric type |
| 8490/3 | Signet ring cell carcinoma |
| 8490/6 | Metastatic signet ring cell carcinoma |
| 8500/2 | Intraductal carcinoma, noninfiltrating, NOS |
| 8500/3 | Infiltrating duct carcinoma, NOS |
| 8501/2 | Comedocarcinoma, noninfiltrating |
| 8501/3 | Comedocarcinoma, NOS |
| 8502/3 | Secretory carcinoma |
| 8503/0 | Intraductal papilloma |
| 8503/2 | Noninfiltrating intraductal papillary adenocarcinoma |
| 8503/3 | Intraductal papillary adenocarcinoma with invasion |
| 8504/0 | Intracystic papillary adenoma |
| 8504/2 | Noninfiltrating intracystic carcinoma |
| 8504/3 | Encapsulated papillary carcinoma with invasion |
| 8505/0 | Intraductal papillomatosis, NOS |
| 8506/0 | Adenoma of nipple |
| 8507/2 | Intraductal micropapillary carcinoma |
| 8507/3 | Invasive micropapillary carcinoma of breast |
| 8508/3 | Cystic hypersecretory carcinoma |
| 8509/2 | Solid papillary carcinoma in situ |
| 8509/3 | Solid papillary carcinoma with invasion |
| 8510/3 | Medullary carcinoma, NOS |
| 8512/3 | Medullary carcinoma with lymphoid stroma |
| 8513/3 | Atypical medullary carcinoma |
| 8514/3 | Duct carcinoma, desmoplastic type |
| 8519/2 | Lobular carcinoma in situ, pleomorphic |
| 8520/2 | Lobular carcinoma in situ, NOS |
| 8520/3 | Lobular carcinoma, NOS |
| 8521/3 | Infiltrating ductular carcinoma |
| 8522/2 | Intraductal carcinoma and lobular carcinoma in situ |
| 8522/3 | Infiltrating duct and lobular carcinoma |
| 8523/3 | Infiltrating duct mixed with other types of carcinoma |
| 8524/3 | Infiltrating lobular mixed with other types of carcinoma |
| 8525/3 | Polymorphous adenocarcinoma |
| 8530/3 | Inflammatory carcinoma |
| 8540/3 | Paget disease, mammary |
| 8541/3 | Paget disease and infiltrating duct carcinoma of breast |
| 8542/3 | Paget disease, extramammary |
| 8543/3 | Paget disease and intraductal carcinoma of breast |
| 8550/0 | Acinar cell adenoma |
| 8550/1 | Acinar cell tumour |
| 8550/3 | Acinar cell carcinoma |
| 8551/3 | Acinar cell cystadenocarcinoma |
| 8552/3 | Mixed acinar-ductal carcinoma |
| 8560/0 | Mixed squamous cell and glandular papilloma |
| 8560/3 | Adenosquamous carcinoma |
| 8561/0 | Adenolymphoma |
| 8562/3 | Epithelial-myoepithelial carcinoma |
| 8563/0 | Lymphadenoma |
| 8570/3 | Adenocarcinoma with squamous metaplasia |
| 8571/3 | Adenocarcinoma with cartilaginous and osseous metaplasia |
| 8572/3 | Adenocarcinoma with spindle cell metaplasia |
| 8573/3 | Adenocarcinoma with apocrine metaplasia |
| 8574/3 | Adenocarcinoma with neuroendocrine differentiation |
| 8575/3 | Metaplastic carcinoma, NOS |
| 8576/3 | Hepatoid adenocarcinoma |
| 8580/0 | Microscopic thymoma |
| 8580/1 | Micronodular thymoma with lymphoid stroma |
| 8580/3 | Thymoma, NOS |
| 8581/3 | Thymoma, type A |
| 8582/3 | Thymoma, type AB |
| 8583/3 | Thymoma, type B1 |
| 8584/3 | Thymoma, type B2 |
| 8585/3 | Thymoma, type B3 |
| 8586/3 | Thymic carcinoma, NOS |
| 8587/0 | Ectopic hamartomatous thymoma |
| 8588/3 | Spindle epithelial tumour with thymus-like element |
| 8589/3 | Intrathyroid thymic carcinoma |
| 8590/0 | Sex cord-stromal tumour, benign |
| 8590/1 | Sex cord-gonadal stromal tumour, NOS |
| 8591/1 | Sex cord-gonadal stromal tumour, incompletely differentiated |
| 8592/1 | Sex cord-gonadal stromal tumour, mixed forms |
| 8593/1 | Stromal tumour with minor sex cord elements |
| 8594/1 | Mixed germ cell-sex cord-stromal tumour, NOS |
| 8600/0 | Thecoma, NOS |
| 8600/3 | Thecoma, malignant |
| 8601/0 | Thecoma, luteinized |
| 8602/0 | Sclerosing stromal tumour |
| 8610/0 | Luteoma, NOS |
| 8620/1 | Adult granulosa cell tumour of testis |
| 8620/3 | Adult granulosa cell tumour of ovary |
| 8621/1 | Granulosa cell-theca cell tumour |
| 8622/0 | Granulosa cell tumour of the testis, juvenile |
| 8622/1 | Granulosa cell tumour, juvenile |
| 8623/1 | Sex cord tumour with annular tubules |
| 8630/0 | Androblastoma, benign |
| 8630/1 | Androblastoma, NOS |
| 8630/3 | Androblastoma, malignant |
| 8631/0 | Sertoli-Leydig cell tumour, well differentiated |
| 8631/1 | Sertoli-Leydig cell tumour of intermediate differentiation |
| 8631/3 | Sertoli-Leydig cell tumour, poorly differentiated |
| 8632/1 | Gynandroblastoma |
| 8633/1 | Sertoli-Leydig cell tumour, retiform |
| 8634/1 | Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements |
| 8634/3 | Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements |
| 8640/1 | Sertoli cell tumour, NOS |
| 8640/3 | Sertoli cell carcinoma |
| 8641/0 | Sertoli cell tumour with lipid storage |
| 8642/1 | Large cell calcifying Sertoli cell tumour |
| 8643/1 | Intratubular large cell hyalinizing Sertoli cell neoplasia |
| 8650/0 | Leydig cell tumour of the ovary, NOS |
| 8650/1 | Leydig cell tumour of the testis, NOS |
| 8650/3 | Leydig cell tumour, malignant |
| 8660/0 | Hilus cell tumour |
| 8670/0 | Lipid cell tumour of ovary |
| 8670/3 | Steroid cell tumour, malignant |
| 8671/0 | Adrenal rest tumour |
| 8680/3 | Paraganglioma, NOS |
| 8681/3 | Sympathetic paraganglioma |
| 8682/3 | Parasympathetic paraganglioma |
| 8683/0 | Gangliocytic paraganglioma |
| 8690/3 | Middle ear paraganglioma |
| 8691/3 | Aortic body tumour |
| 8692/3 | Carotid body paraganglioma |
| 8693/3 | Extra-adrenal paraganglioma |
| 8700/3 | Pheochromocytoma, NOS |
| 8710/3 | Glomangiosarcoma |
| 8711/0 | Glomus tumour, NOS |
| 8711/1 | Glomangiomatosis |
| 8711/3 | Glomus tumour, malignant |
| 8712/0 | Glomangioma |
| 8713/0 | Glomangiomyoma |
| 8714/0 | Perivascular epithelioid tumour, benign |
| 8714/3 | Perivascular epithelioid tumour, malignant |
| 8720/0 | Pigmented naevus, NOS |
| 8720/2 | Melanoma in situ |
| 8720/3 | Malignant melanoma, NOS |
| 8721/3 | Nodular melanoma |
| 8722/0 | Balloon cell naevus |
| 8722/3 | Balloon cell melanoma |
| 8723/0 | Halo naevus |
| 8723/3 | Malignant melanoma, regressing |
| 8725/0 | Neuronevus |
| 8726/0 | Magnocellular naevus |
| 8727/0 | Dysplastic naevus |
| 8728/0 | Meningeal melanocytosis |
| 8728/1 | Meningeal melanocytoma |
| 8728/3 | Meningeal melanomatosis |
| 8730/0 | Nonpigmented naevus |
| 8730/3 | Amelanotic melanoma |
| 8740/0 | Junctional naevus, NOS |
| 8740/3 | Malignant melanoma in junctional naevus |
| 8741/2 | Precancerous melanosis, NOS |
| 8741/3 | Malignant melanoma in precancerous melanosis |
| 8742/0 | Lentiginous melanocytic naevus |
| 8742/2 | Lentigo maligna |
| 8742/3 | Lentigo maligna melanoma |
| 8743/3 | Low cumulative sun damage melanoma |
| 8744/0 | Acral naevus |
| 8744/3 | Acral melanoma |
| 8745/3 | Desmoplastic melanoma, NOS |
| 8746/3 | Mucosal lentiginous melanoma |
| 8750/0 | Dermal naevus |
| 8760/0 | Compound naevus |
| 8761/0 | Congenital melanocytic naevus, NOS |
| 8761/1 | Giant pigmented naevus, NOS |
| 8761/3 | Malignant melanoma arising in giant congenital naevus |
| 8762/1 | Proliferative dermal lesion in congenital naevus |
| 8770/0 | Epithelioid and spindle cell naevus |
| 8770/3 | Malignant Spitz tumour |
| 8771/0 | Epithelioid cell naevus |
| 8771/3 | Epithelioid cell melanoma |
| 8772/0 | Spindle cell naevus, NOS |
| 8772/3 | Spindle cell melanoma, NOS |
| 8773/3 | Spindle cell melanoma, type A |
| 8774/3 | Spindle cell melanoma, type B |
| 8780/0 | Blue nevus, NOS |
| 8780/1 | Pigmented epithelioid melanocytoma |
| 8780/3 | Blue naevus, malignant |
| 8790/0 | Cellular blue naevus |
| 8800/0 | Soft tissue tumour, benign |
| 8800/3 | Sarcoma, NOS |
| 8800/9 | Sarcomatosis, NOS |
| 8801/3 | Spindle cell sarcoma |
| 8802/1 | Pleomorphic hyalinizing angiectatic tumour |
| 8802/3 | Giant cell sarcoma |
| 8803/3 | Small cell sarcoma |
| 8804/3 | Epithelioid sarcoma |
| 8805/3 | Undifferentiated sarcoma |
| 8806/3 | Desmoplastic small round cell tumour |
| 8810/0 | Fibroma, NOS |
| 8810/1 | Cellular fibroma |
| 8810/3 | Fibrosarcoma, NOS |
| 8811/0 | Fibromyxoma |
| 8811/1 | Myxoinflammatory fibroblastic sarcoma |
| 8811/3 | Myxofibrosarcoma |
| 8812/0 | Periosteal fibroma |
| 8812/3 | Periosteal fibrosarcoma |
| 8813/0 | Fibroma of tendon sheath |
| 8813/1 | Palmar/plantar type fibromatosis |
| 8813/3 | Fascial fibrosarcoma |
| 8814/3 | Infantile fibrosarcoma |
| 8815/0 | Solitary fibrous tumour/Haemangiopericytoma, grade 1 |
| 8815/1 | Solitary fibrous tumour, NOS |
| 8815/3 | Solitary fibrous tumour, malignant |
| 8816/0 | Calcifying aponeurotic fibroma |
| 8817/0 | Calcifying fibrous tumour |
| 8818/0 | Fibrous dysplasia |
| 8820/0 | Elastofibroma |
| 8821/1 | Aggressive fibromatosis |
| 8822/1 | Abdominal fibromatosis |
| 8823/0 | Sclerotic fibroma |
| 8823/1 | Desmoplastic fibroma |
| 8824/0 | Myofibroma |
| 8824/1 | Myofibromatosis |
| 8825/0 | Myofibroblastoma |
| 8825/1 | Myofibroblastic tumour, NOS |
| 8825/3 | Myofibroblastic sarcoma |
| 8826/0 | Angiomyofibroblastoma |
| 8827/1 | Myofibroblastic tumour, peribronchial |
| 8828/0 | Nodular fasciitis |
| 8830/0 | Benign fibrous histiocytoma |
| 8830/1 | Atypical fibrous histiocytoma |
| 8830/3 | Malignant fibrous histiocytoma |
| 8831/0 | Histiocytoma, NOS |
| 8832/0 | Dermatofibroma, NOS |
| 8832/1 | Dermatofibrosarcoma protuberans, NOS |
| 8832/3 | Dermatofibrosarcoma protuberans, fibrosarcomatous |
| 8833/1 | Pigmented dermatofibrosarcoma protuberans |
| 8834/1 | Giant cell fibroblastoma |
| 8835/1 | Plexiform fibrohistiocytic tumour |
| 8836/1 | Angiomatoid fibrous histiocytoma |
| 8840/0 | Myxoma, NOS |
| 8840/3 | Myxosarcoma |
| 8841/0 | Angiomyxoma |
| 8842/0 | Ossifying fibromyxoid tumour |
| 8842/3 | Ossifying fibromyxoid tumour, malignant |
| 8850/0 | Lipoma, NOS |
| 8850/1 | Atypical lipomatous tumour |
| 8850/3 | Liposarcoma, NOS |
| 8851/0 | Fibrolipoma |
| 8851/1 | Lipofibromatosis |
| 8851/3 | Liposarcoma, well differentiated |
| 8852/0 | Fibromyxolipoma |
| 8852/3 | Myxoid liposarcoma |
| 8854/0 | Pleomorphic lipoma |
| 8854/3 | Pleomorphic liposarcoma |
| 8855/3 | Mixed liposarcoma |
| 8856/0 | Intramuscular lipoma |
| 8857/0 | Spindle cell lipoma |
| 8857/3 | Fibroblastic liposarcoma |
| 8858/3 | Dedifferentiated liposarcoma |
| 8860/0 | Angiomyolipoma |
| 8860/1 | Angiomyolipoma, Epithelioid |
| 8861/0 | Angiolipoma, NOS |
| 8862/0 | Chondroid lipoma |
| 8870/0 | Myelolipoma |
| 8880/0 | Hibernoma |
| 8881/0 | Lipoblastomatosis |
| 8890/0 | Leiomyoma, NOS |
| 8890/1 | Leiomyomatosis, NOS |
| 8890/3 | Leiomyosarcoma, NOS |
| 8891/0 | Epithelioid leiomyoma |
| 8891/3 | Epithelioid leiomyosarcoma |
| 8892/0 | Cellular leiomyoma |
| 8893/0 | Bizarre leiomyoma |
| 8894/0 | Angiomyoma |
| 8894/3 | Angiomyosarcoma |
| 8895/0 | Myoma |
| 8895/3 | Myosarcoma |
| 8896/0 | Myxoid leiomyoma |
| 8896/3 | Myxoid leiomyosarcoma |
| 8897/1 | Smooth muscle tumour of uncertain malignant potential |
| 8898/1 | Metastasizing leiomyoma |
| 8900/0 | Rhabdomyoma, NOS |
| 8900/3 | Rhabdomyosarcoma, NOS |
| 8901/3 | Pleomorphic rhabdomyosarcoma, adult type |
| 8902/3 | Mixed type rhabdomyosarcoma |
| 8903/0 | Fetal rhabdomyoma |
| 8904/0 | Adult cellular rhabdomyoma |
| 8905/0 | Genital rhabdomyoma |
| 8910/3 | Embryonal rhabdomyosarcoma, NOS |
| 8912/3 | Spindle cell rhabdomyosarcoma |
| 8920/3 | Alveolar rhabdomyosarcoma |
| 8921/3 | Ectomesenchymoma |
| 8930/0 | Endometrial stromal nodule |
| 8930/3 | Endometrial stromal sarcoma, NOS |
| 8931/3 | Endometrial stromal sarcoma, low grade |
| 8932/0 | Adenomyoma |
| 8933/3 | Adenosarcoma |
| 8934/3 | Carcinofibroma |
| 8935/0 | Stromal tumour, benign |
| 8935/1 | Stromal tumour, NOS |
| 8935/3 | Stromal sarcoma, NOS |
| 8936/3 | Gastrointestinal stromal tumour |
| 8940/0 | Pleomorphic adenoma |
| 8940/3 | Mixed tumour, malignant, NOS |
| 8941/3 | Carcinoma ex pleomorphic adenoma |
| 8950/3 | Mullerian mixed tumour |
| 8951/3 | Mesodermal mixed tumour |
| 8959/0 | Benign cystic nephroma |
| 8959/1 | Cystic partially differentiated nephroblastoma |
| 8959/3 | Malignant cystic nephroma |
| 8960/1 | Mesoblastic nephroma |
| 8960/3 | Nephroblastoma, NOS |
| 8963/3 | Rhabdoid tumour, NOS |
| 8964/3 | Clear cell sarcoma of kidney |
| 8966/0 | Renomedullary interstitial cell tumour |
| 8967/0 | Ossifying renal tumour |
| 8970/3 | Hepatoblastoma |
| 8971/3 | Pancreatoblastoma |
| 8972/3 | Pulmonary blastoma |
| 8973/3 | Pleuropulmonary blastoma |
| 8974/1 | Sialoblastoma |
| 8975/1 | Calcifying nested stromal-epithelial tumour |
| 8980/3 | Carcinosarcoma, NOS |
| 8981/3 | Carcinosarcoma, embryonal |
| 8982/0 | Myoepithelioma |
| 8982/3 | Myoepithelial carcinoma |
| 8983/0 | Adenomyoepithelioma, NOS |
| 8983/3 | Adenomyoepithelioma with carcinoma |
| 8990/0 | Mesenchymoma, benign |
| 8990/1 | Mesenchymoma, NOS |
| 8990/3 | Mesenchymoma, malignant |
| 8991/3 | Embryonal sarcoma |
| 8992/0 | Pulmonary hamartoma |
| 9000/0 | Brenner tumour, NOS |
| 9000/1 | Brenner tumour, borderline malignancy |
| 9000/3 | Brenner tumour, malignant |
| 9010/0 | Fibroadenoma, NOS |
| 9011/0 | Intracanalicular fibroadenoma |
| 9012/0 | Pericanalicular fibroadenoma |
| 9013/0 | Adenofibroma, NOS |
| 9014/0 | Serous adenofibroma, NOS |
| 9014/1 | Serous adenofibroma of borderline malignancy |
| 9014/3 | Serous adenocarcinofibroma |
| 9015/0 | Mucinous adenofibroma, NOS |
| 9015/1 | Mucinous adenofibroma of borderline malignancy |
| 9015/3 | Mucinous adenocarcinofibroma |
| 9016/0 | Giant fibroadenoma |
| 9020/0 | Phyllodes tumour, benign |
| 9020/1 | Phyllodes tumour, borderline |
| 9020/3 | Phyllodes tumour, malignant |
| 9030/0 | Juvenile fibroadenoma |
| 9040/0 | Synovioma, benign |
| 9040/3 | Synovial sarcoma, NOS |
| 9041/3 | Synovial sarcoma, spindle cell |
| 9042/3 | Synovial sarcoma, epithelioid cell |
| 9043/3 | Synovial sarcoma, biphasic |
| 9044/3 | Clear cell sarcoma, NOS |
| 9045/3 | Biphenotypic sinonasal sarcoma |
| 9050/0 | Mesothelioma, benign |
| 9050/3 | Mesothelioma, malignant |
| 9051/0 | Fibrous mesothelioma, benign |
| 9051/3 | Fibrous mesothelioma, malignant |
| 9052/0 | Epithelioid mesothelioma, benign |
| 9052/1 | Well differentiated papillary mesothelioma of the pleura |
| 9052/3 | Epithelioid mesothelioma, malignant |
| 9053/3 | Mesothelioma, biphasic, malignant |
| 9054/0 | Adenomatoid tumour, NOS |
| 9055/0 | Peritoneal inclusion cysts |
| 9060/3 | Dysgerminoma |
| 9061/3 | Seminoma, NOS |
| 9062/3 | Seminoma, anaplastic |
| 9063/3 | Spermatocytic seminoma |
| 9064/2 | Intratubular malignant germ cells |
| 9064/3 | Germinoma |
| 9065/3 | Germ cell tumour, nonseminomatous |
| 9070/3 | Embryonal carcinoma, NOS |
| 9071/3 | Yolk sac tumour |
| 9072/3 | Polyembryoma |
| 9073/1 | Gonadoblastoma |
| 9080/0 | Teratoma, benign |
| 9080/1 | Teratoma, NOS |
| 9080/3 | Teratoma, malignant, NOS |
| 9081/3 | Teratocarcinoma |
| 9082/3 | Malignant teratoma, undifferentiated |
| 9083/3 | Malignant teratoma, intermediate |
| 9084/0 | Dermoid cyst, NOS |
| 9084/3 | Teratoma with malignant transformation |
| 9085/3 | Mixed germ cell tumour |
| 9086/3 | Germ cell tumour with associated haematological malignancy |
| 9090/0 | Struma ovarii, NOS |
| 9090/3 | Struma ovarii, malignant |
| 9091/1 | Strumal carcinoid |
| 9100/0 | Hydatidiform mole, NOS |
| 9100/1 | Invasive hydatidiform mole |
| 9100/3 | Choriocarcinoma, NOS |
| 9101/3 | Choriocarcinoma combined with other germ cell elements |
| 9102/3 | Malignant teratoma, trophoblastic |
| 9103/0 | Partial hydatidiform mole |
| 9104/1 | Placental site trophoblastic tumour |
| 9105/3 | Trophoblastic tumour, epithelioid |
| 9110/0 | Adenoma of rete ovarii |
| 9110/1 | Wolffian tumour |
| 9110/3 | Mesonephroma, malignant |
| 9120/0 | Haemangioma, NOS |
| 9120/3 | Hemangiosarcoma |
| 9121/0 | Cavernous haemangioma |
| 9122/0 | Venous haemangioma |
| 9123/0 | Racemose haemangioma |
| 9124/3 | Kupffer cell sarcoma |
| 9125/0 | Epithelioid haemangioma |
| 9126/0 | Atypical vascular lesion |
| 9130/0 | Haemangioendothelioma, benign |
| 9130/1 | Haemangioendothelioma, NOS |
| 9130/3 | Haemangioendothelioma, malignant |
| 9131/0 | Capillary haemangioma |
| 9132/0 | Intramuscular haemangioma |
| 9133/3 | Epithelioid haemangioendothelioma, NOS |
| 9135/1 | Papillary intralymphatic angioendothelioma |
| 9136/1 | Spindle cell haemangioendothelioma |
| 9137/0 | Myointimoma |
| 9137/3 | Intimal sarcoma |
| 9138/1 | Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma |
| 9140/3 | Kaposi sarcoma |
| 9141/0 | Angiokeratoma |
| 9142/0 | Verrucous keratotic haemangioma |
| 9160/0 | Angiofibroma, NOS |
| 9161/0 | Acquired tufted haemangioma |
| 9161/1 | Haemangioblastoma |
| 9170/0 | Lymphangioma, NOS |
| 9170/3 | Lymphangiosarcoma |
| 9171/0 | Capillary lymphangioma |
| 9172/0 | Cavernous lymphangioma |
| 9173/0 | Cystic lymphangioma |
| 9174/0 | Lymphangiomyoma |
| 9174/1 | Lymphangiomyomatosis |
| 9175/0 | Haemolymphangioma |
| 9180/0 | Osteoma, NOS |
| 9180/3 | Osteosarcoma, NOS |
| 9181/3 | Chondroblastic osteosarcoma |
| 9182/3 | Fibroblastic osteosarcoma |
| 9183/3 | Telangiectatic osteosarcoma |
| 9184/3 | Osteosarcoma in Paget disease of bone |
| 9185/3 | Small cell osteosarcoma |
| 9186/3 | Central osteosarcoma |
| 9187/3 | Low grade central osteosarcoma |
| 9191/0 | Osteoid osteoma, NOS |
| 9192/3 | Parosteal osteosarcoma |
| 9193/3 | Periosteal osteosarcoma |
| 9194/3 | High grade surface osteosarcoma |
| 9195/3 | Intracortical osteosarcoma |
| 9200/0 | Osteoblastoma, NOS |
| 9200/1 | Aggressive osteoblastoma |
| 9210/0 | Osteochondroma |
| 9210/1 | Osteochondromatosis, NOS |
| 9211/0 | Osteochondromyxoma |
| 9212/0 | Bizarre parosteal osteochondromatous proliferation |
| 9213/0 | Subungual exostosis |
| 9220/0 | Chondroma, NOS |
| 9220/1 | Chondromatosis, NOS |
| 9220/3 | Chondrosarcoma, NOS |
| 9221/0 | Periosteal chondroma |
| 9221/3 | Periosteal chondrosarcoma |
| 9222/1 | Atypical cartilaginous tumour |
| 9230/1 | Chondroblastoma, NOS |
| 9230/3 | Chondroblastoma, malignant |
| 9231/3 | Myxoid chondrosarcoma |
| 9240/3 | Mesenchymal chondrosarcoma |
| 9241/0 | Chondromyxoid fibroma |
| 9242/3 | Clear cell chondrosarcoma |
| 9243/3 | Dedifferentiated chondrosarcoma |
| 9250/1 | Giant cell tumour of bone, NOS |
| 9250/3 | Giant cell tumour of bone, malignant |
| 9251/1 | Giant cell tumour of soft parts, NOS |
| 9251/3 | Malignant giant cell tumour of soft parts |
| 9252/0 | Tenosynovial giant cell tumour, NOS |
| 9252/1 | Tenosynovial giant cell tumour, diffuse |
| 9252/3 | Malignant tenosynovial giant cell tumour |
| 9260/0 | Aneurysmal bone cyst |
| 9261/3 | Adamantinoma of long bones |
| 9262/0 | Ossifying fibroma |
| 9270/0 | Odontogenic tumour, benign |
| 9270/1 | Odontogenic tumour, NOS |
| 9270/3 | Odontogenic tumour, malignant |
| 9271/0 | Ameloblastic fibrodentinoma |
| 9272/0 | Cementoma, NOS |
| 9273/0 | Cementoblastoma, benign |
| 9274/0 | Cemento-ossifying fibroma |
| 9275/0 | Gigantiform cementoma |
| 9280/0 | Odontoma, NOS |
| 9281/0 | Compound odontoma |
| 9282/0 | Complex odontoma |
| 9290/0 | Ameloblastic fibro-odontoma |
| 9290/3 | Ameloblastic odontosarcoma |
| 9300/0 | Adenomatoid odontogenic tumour |
| 9301/0 | Calcifying odontogenic cyst |
| 9302/0 | Dentinogenic ghost cell tumour |
| 9302/3 | Ghost cell odontogenic carcinoma |
| 9310/0 | Ameloblastoma, NOS |
| 9310/3 | Ameloblastoma, metastasizing |
| 9311/0 | Odontoameloblastoma |
| 9312/0 | Squamous odontogenic tumour |
| 9320/0 | Odontogenic myxoma |
| 9321/0 | Odontogenic fibroma, NOS |
| 9322/0 | Peripheral odontogenic fibroma |
| 9330/0 | Ameloblastic fibroma |
| 9330/3 | Ameloblastic fibrosarcoma |
| 9340/0 | Calcifying epithelial odontogenic tumour |
| 9341/3 | Clear cell odontogenic carcinoma |
| 9342/3 | Odontogenic carcinosarcoma |
| 9350/1 | Craniopharyngioma |
| 9351/1 | Craniopharyngioma, adamantinomatous |
| 9352/1 | Craniopharyngioma, papillary |
| 9360/1 | Pinealoma |
| 9361/1 | Pineocytoma |
| 9362/3 | Pineoblastoma |
| 9363/0 | Melanotic neuroectodermal tumour |
| 9364/3 | Ewing sarcoma |
| 9365/3 | Askin tumour |
| 9370/0 | Benign notochordal cell tumour |
| 9370/3 | Chordoma, NOS |
| 9371/3 | Chondroid chordoma |
| 9372/3 | Dedifferentiated chordoma |
| 9373/0 | Parachordoma |
| 9380/3 | Glioma, malignant |
| 9381/3 | Gliomatosis cerebri |
| 9382/3 | Oligoastrocytoma, NOS |
| 9383/1 | Subependymoma |
| 9384/1 | Subependymal giant cell astrocytoma |
| 9385/3 | Diffuse midline glioma, H3 K27M-mutant |
| 9390/0 | Choroid plexus papilloma, NOS |
| 9390/1 | Atypical choroid plexus papilloma |
| 9390/3 | Choroid plexus carcinoma |
| 9391/1 | Sellar ependymoma |
| 9391/3 | Ependymoma, NOS |
| 9392/3 | Ependymoma, anaplastic |
| 9393/3 | Papillary ependymoma |
| 9394/1 | Myxopapillary ependymoma |
| 9395/3 | Papillary tumour of the pineal region |
| 9396/3 | Ependymoma, RELA fusion-positive |
| 9400/3 | Astrocytoma, NOS |
| 9401/3 | Astrocytoma, anaplastic |
| 9410/3 | Protoplasmic astrocytoma |
| 9411/3 | Gemistocytic astrocytoma |
| 9412/1 | Desmoplastic infantile astrocytoma |
| 9413/0 | Dysembryoplastic neuroepithelial tumour |
| 9420/3 | Fibrillary astrocytoma |
| 9421/1 | Pilocytic astrocytoma |
| 9423/3 | Polar spongioblastoma |
| 9424/3 | Pleomorphic xanthoastrocytoma |
| 9425/3 | Pilomyxoid astrocytoma |
| 9430/3 | Astroblastoma |
| 9431/1 | Angiocentric glioma |
| 9432/1 | Pituicytoma |
| 9440/3 | Glioblastoma, NOS |
| 9441/3 | Giant cell glioblastoma |
| 9442/1 | Gliofibroma |
| 9442/3 | Gliosarcoma |
| 9444/1 | Chordoid glioma |
| 9445/3 | Glioblastoma, IDH mutant |
| 9450/3 | Oligodendroglioma, NOS |
| 9451/3 | Oligodendroglioma, anaplastic |
| 9460/3 | Oligodendroblastoma |
| 9470/3 | Medulloblastoma, NOS |
| 9471/3 | Desmoplastic nodular medulloblastoma |
| 9472/3 | Medullomyoblastoma |
| 9473/3 | CNS embryonal tumour, NOS |
| 9474/3 | Large cell medulloblastoma |
| 9475/3 | Medulloblastoma, WNT-activated, NOS |
| 9476/3 | Medulloblastoma, SHH-activated and TP53-mutant |
| 9477/3 | Medulloblastoma, non-WNT/non-SHH |
| 9478/3 | Embryonal tumours with multilayered rosettes with C19MC alteration |
| 9480/3 | Cerebellar sarcoma, NOS |
| 9490/0 | Ganglioneuroma |
| 9490/3 | Ganglioneuroblastoma |
| 9491/0 | Ganglioneuromatosis |
| 9492/0 | Gangliocytoma |
| 9493/0 | Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) |
| 9500/3 | Neuroblastoma, NOS |
| 9501/0 | Medulloepithelioma, benign |
| 9501/3 | Medulloepithelioma, NOS |
| 9502/0 | Teratoid medulloepithelioma, benign |
| 9502/3 | Teratoid medulloepithelioma |
| 9503/3 | Neuroepithelioma, NOS |
| 9504/3 | Spongioneuroblastoma |
| 9505/1 | Ganglioglioma, NOS |
| 9505/3 | Ganglioglioma, anaplastic |
| 9506/1 | Central neurocytoma |
| 9507/0 | Pacinian tumour |
| 9508/3 | Atypical teratoid/rhabdoid tumour |
| 9509/1 | Papillary glioneuronal tumour |
| 9510/0 | Retinocytoma |
| 9510/3 | Retinoblastoma, NOS |
| 9511/3 | Retinoblastoma, differentiated |
| 9512/3 | Retinoblastoma, undifferentiated |
| 9513/3 | Retinoblastoma, diffuse |
| 9514/1 | Retinoblastoma, spontaneously regressed |
| 9520/3 | Olfactory neurogenic tumour |
| 9521/3 | Olfactory neurocytoma |
| 9522/3 | Olfactory neuroblastoma |
| 9523/3 | Olfactory neuroepithelioma |
| 9530/0 | Meningioma, NOS |
| 9530/3 | Meningioma, malignant |
| 9531/0 | Meningothelial meningioma |
| 9532/0 | Fibrous meningioma |
| 9533/0 | Psammomatous meningioma |
| 9534/0 | Angiomatous meningioma |
| 9535/0 | Haemangioblastic meningioma |
| 9537/0 | Transitional meningioma |
| 9538/1 | Clear cell meningioma |
| 9538/3 | Papillary meningioma |
| 9539/1 | Atypical meningioma |
| 9539/3 | Meningeal sarcomatosis |
| 9540/0 | Neurofibroma, NOS |
| 9540/3 | Malignant peripheral nerve sheath tumour |
| 9541/0 | Melanotic neurofibroma |
| 9542/3 | Malignant peripheral nerve sheath tumour, epithelioid |
| 9550/0 | Plexiform neurofibroma |
| 9560/0 | Schwannoma, NOS |
| 9560/1 | Melanotic schwannoma |
| 9560/3 | Neurilemoma, malignant |
| 9561/3 | Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation |
| 9562/0 | Nerve sheath myxoma |
| 9563/0 | Nerve sheath tumour, NOS |
| 9570/0 | Neuroma, NOS |
| 9571/0 | Perineurioma, NOS |
| 9571/3 | Perineurioma, malignant |
| 9580/0 | Granular cell tumour, NOS |
| 9580/3 | Granular cell tumour, malignant |
| 9581/3 | Alveolar soft part sarcoma |
| 9582/0 | Granular cell tumour of the sellar region |
| 9590/3 | Malignant lymphoma, NOS |
| 9591/1 | Monoclonal B-cell lymphocytosis, NOS |
| 9591/3 | Malignant lymphoma, non-Hodgkin, NOS |
| 9596/3 | Composite Hodgkin and non-Hodgkin lymphoma |
| 9597/3 | Primary cutaneous follicle centre lymphoma |
| 9650/3 | Hodgkin lymphoma, NOS |
| 9651/3 | Hodgkin lymphoma, lymphocyte-rich |
| 9652/3 | Hodgkin lymphoma, mixed cellularity, NOS |
| 9653/3 | Hodgkin lymphoma, lymphocyte depletion, NOS |
| 9654/3 | Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis |
| 9655/3 | Hodgkin lymphoma, lymphocyte depletion, reticular |
| 9659/3 | Hodgkin lymphoma, nodular lymphocyte predominant |
| 9661/3 | Hodgkin granuloma |
| 9662/3 | Hodgkin sarcoma |
| 9663/3 | Hodgkin lymphoma, nodular sclerosis, NOS |
| 9664/3 | Hodgkin lymphoma, nodular sclerosis, cellular phase |
| 9665/3 | Hodgkin lymphoma, nodular sclerosis, grade 1 |
| 9667/3 | Hodgkin lymphoma, nodular sclerosis, grade 2 |
| 9671/3 | Lymphoplasmacytic lymphoma |
| 9673/1 | In situ mantle cell neoplasia |
| 9673/3 | Mantle cell lymphoma |
| 9675/3 | Malignant lymphoma, mixed small and large cell, diffuse |
| 9678/3 | Primary effusion lymphoma |
| 9679/3 | Mediastinal large B-cell lymphoma |
| 9680/1 | EBV positive mucocutaneous ulcer |
| 9680/3 | Diffuse large B-cell lymphoma, NOS |
| 9684/3 | Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS |
| 9687/3 | Burkitt lymphoma, NOS |
| 9688/3 | T-cell/histiocyte rich large B-cell lymphoma |
| 9689/3 | Splenic marginal zone B-cell lymphoma |
| 9690/3 | Follicular lymphoma, NOS |
| 9691/3 | Follicular lymphoma, grade 2 |
| 9695/1 | In situ follicular neoplasia |
| 9695/3 | Follicular lymphoma, grade 1 |
| 9698/3 | Follicular lymphoma, grade 3 |
| 9699/3 | Marginal zone B-cell lymphoma, NOS |
| 9700/3 | Mycosis fungoides |
| 9701/3 | Sezary syndrome |
| 9702/1 | Indolent T-cell lymphoproliferative disorder of gastrointestinal tract |
| 9702/3 | Mature T-cell lymphoma, NOS |
| 9705/3 | Angioimmunoblastic T-cell lymphoma |
| 9708/3 | Subcutaneous panniculitis-like T-cell lymphoma |
| 9709/1 | Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder |
| 9709/3 | Cutaneous T-cell lymphoma, NOS |
| 9712/3 | Intravascular large B-cell lymphoma |
| 9714/3 | Anaplastic large cell lymphoma, T cell and Null cell type |
| 9715/3 | Anaplastic large cell lymphoma, ALK negative |
| 9716/3 | Hepatosplenic T-cell lymphoma |
| 9717/3 | Intestinal T-cell lymphoma |
| 9718/1 | Primary cutaneous CD30+ T-cell lymphoproliferative disorder |
| 9718/3 | Primary cutaneous anaplastic large cell lymphoma |
| 9719/3 | NK/T-cell lymphoma, nasal and nasal-type |
| 9724/3 | Systemic EBV positive T-cell lymphoproliferative disease of childhood |
| 9725/1 | Hydroa vacciniforme-like lymphoproliferative disorder |
| 9726/3 | Primary cutaneous gamma/delta T-cell lymphoma |
| 9727/3 | Precursor cell lymphoblastic lymphoma, NOS |
| 9731/3 | Plasmacytoma, NOS |
| 9732/3 | Plasma cell myeloma |
| 9733/3 | Plasma cell leukaemia |
| 9734/3 | Plasmacytoma, extramedullary |
| 9735/3 | Plasmablastic lymphoma |
| 9737/3 | ALK positive large B-cell lymphoma |
| 9738/3 | Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease |
| 9740/1 | Mastocytoma, NOS |
| 9740/3 | Mast cell sarcoma |
| 9741/1 | Indolent systemic mastocytosis |
| 9741/3 | Malignant mastocytosis |
| 9742/3 | Mast cell leukaemia |
| 9749/3 | Erdheim-Chester disease |
| 9750/3 | Malignant histiocytosis |
| 9751/1 | Langerhans cell histiocytosis |
| 9751/3 | Langerhans cell histiocytosis, disseminated |
| 9755/3 | Histiocytic sarcoma |
| 9756/3 | Langerhans cell sarcoma |
| 9757/3 | Interdigitating dendritic cell sarcoma |
| 9758/3 | Follicular dendritic cell sarcoma |
| 9759/3 | Fibroblastic reticular cell tumour |
| 9760/3 | Immunoproliferative disease, NOS |
| 9761/1 | IgM monoclonal gammopathy of undetermined significance |
| 9761/3 | Waldenstrom macroglobulinemia |
| 9762/3 | Heavy chain disease, NOS |
| 9764/3 | Immunoproliferative small intestinal disease |
| 9765/1 | Monoclonal gammopathy of undetermined significance |
| 9766/1 | Angiocentric immunoproliferative lesion |
| 9766/3 | Lymphomatoid granulomatosis, grade 3 |
| 9767/1 | Angioimmunoblastic lymphadenopathy (AIL) |
| 9768/1 | T-gamma lymphoproliferative disease |
| 9769/1 | Immunoglobulin deposition disease |
| 9800/3 | Leukaemia, NOS |
| 9801/3 | Acute leukaemia, NOS |
| 9805/3 | Acute biphenotypic leukaemia |
| 9806/3 | Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 |
| 9807/3 | Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged |
| 9808/3 | Mixed phenotype acute leukaemia, B/myeloid, NOS |
| 9809/3 | Mixed phenotype acute leukaemia, T/myeloid, NOS |
| 9811/3 | B lymphoblastic leukaemia/lymphoma, NOS |
| 9812/3 | B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 |
| 9813/3 | B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged |
| 9814/3 | B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) |
| 9815/3 | B lymphoblastic leukaemia/lymphoma with hyperdiploidy |
| 9816/3 | B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) |
| 9817/3 | B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH |
| 9818/3 | B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) |
| 9819/3 | B lymphoblastic leukemia/lymphoma, BCR-ABL1-like |
| 9820/3 | Lymphoid leukaemia, NOS |
| 9823/1 | Monoclonal B-cell lymphocytosis, CLL type |
| 9823/3 | B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma |
| 9827/3 | Adult T-cell leukaemia/lymphoma (HTLV-1 positive) |
| 9831/3 | T-cell large granular lymphocytic leukaemia |
| 9832/3 | Prolymphocytic leukaemia, NOS |
| 9833/3 | Prolymphocytic leukaemia, B-cell type |
| 9834/3 | Prolymphocytic leukaemia, T-cell type |
| 9835/3 | Precursor cell lymphoblastic leukaemia, NOS |
| 9837/3 | Precursor T-cell lymphoblastic leukaemia |
| 9840/3 | Acute erythroid leukemia |
| 9860/3 | Myeloid leukaemia, NOS |
| 9861/3 | Acute myeloid leukaemia, NOS |
| 9863/3 | Chronic myeloid leukaemia, NOS |
| 9865/3 | Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214 |
| 9866/3 | Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) |
| 9867/3 | Acute myelomonocytic leukaemia |
| 9869/3 | Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1 |
| 9870/3 | Acute basophilic leukaemia |
| 9871/3 | Acute myeloid leukaemia with abnormal marrow eosinophils |
| 9872/3 | Acute myeloid leukaemia, minimal differentiation |
| 9873/3 | Acute myeloid leukaemia without maturation |
| 9874/3 | Acute myeloid leukaemia with maturation |
| 9875/3 | Chronic myelogenous leukaemia, BCR/ABL positive |
| 9876/3 | Atypical chronic myeloid leukaemia, BCR/ABL negative |
| 9877/3 | Acute myeloid leukaemia with mutated NPM1 |
| 9878/3 | Acute myeloid leukemia with biallelic mutation of CEBPA |
| 9879/3 | Acute myeloid leukemia with mutated RUNX1 |
| 9891/3 | Acute monocytic leukaemia |
| 9895/3 | Acute myeloid leukaemia with myelodysplasia-related changes |
| 9896/3 | Acute myeloid leukaemia, t(8;21)(q22;q22) |
| 9897/3 | Acute myeloid leukaemia, 11q23 abnormalities |
| 9898/1 | Transient abnormal myelopoiesis |
| 9898/3 | Myeloid leukaemia associated with Down Syndrome |
| 9910/3 | Acute megakaryoblastic leukaemia |
| 9911/3 | Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 |
| 9912/3 | Acute myeloid leukemia with BCR-ABL1 |
| 9920/3 | Therapy related myeloid neoplasm |
| 9930/3 | Myeloid sarcoma |
| 9931/3 | Acute panmyelosis with myelofibrosis |
| 9940/3 | Hairy cell leukaemia |
| 9945/3 | Chronic myelomonocytic leukaemia, NOS |
| 9946/3 | Juvenile myelomonocytic leukaemia |
| 9948/3 | Aggressive NK-cell leukaemia |
| 9950/3 | Polycythaemia vera |
| 9960/3 | Myeloproliferative neoplasm, NOS |
| 9961/3 | Primary myelofibrosis |
| 9962/3 | Essential thrombocythemia |
| 9963/3 | Chronic neutrophilic leukaemia |
| 9964/3 | Chronic eosinophilic leukaemia |
| 9965/3 | Myeloid and lymphoid neoplasms with PDGFRA rearrangement |
| 9966/3 | Myeloid neoplasms with PDGFRB rearrangement |
| 9967/3 | Myeloid and lymphoid neoplasms with FGFR1 abnormalities |
| 9968/3 | Myeloid or lymphoid neoplasm with PCM1-JAK2 |
| 9970/1 | Lymphoproliferative disorder, NOS |
| 9971/1 | Post transplant lymphoproliferative disorder, NOS |
| 9975/3 | Myeloproliferative neoplasm, unclassifiable |
| 9982/3 | Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia |
| 9983/3 | Myelodysplastic syndrome with excess blasts |
| 9984/3 | Refractory anaemia with excess blasts in transformation |
| 9985/3 | Myelodysplastic syndrome with multilineage dysplasia |
| 9986/3 | Myelodysplastic syndrome with isolated del (5q) |
| 9987/3 | Therapy-related myelodysplastic syndrome, NOS |
| 9989/3 | Myelodysplastic syndrome, NOS |
| 9993/3 | Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
| 8408/3 | Digital papillary adenocarcinoma |
| 8442/1 | Serous borderline tumour, NOS |
| 9980/3 | Myelodysplastic syndrome with single lineage dysplasia |
Expansion based on code system fragment http://terminology.hl7.org/CodeSystem/icd-o-3 International Classification of Diseases for Oncology, version 3. version 2000
Expansion from tx.fhir.org based on codesystem International Classification of Diseases for Oncology, version 3. version 2000
This value set contains at least 3 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2026+ MyHealth@Eu. Package myhealth.eu.fhir.eps#1.0.0-ci-build based on FHIR 4.0.1. Generated 2026-03-31
